research Combined Low Laser Light Phototherapy and Growth Factor Hair Formulation Infiltration Therapy in Androgenetic Alopecia
Combining laser light therapy and growth factor treatment improves hair growth in people with hair loss.
Search
for
Sort by
Research
540-570 / 1000+ results
research Androgenetic Alopecia
Androgenetic alopecia (AGA) is a common, hereditary hair loss condition that can be slowed but not permanently reversed with available therapies.
research Progenic Hair Regrowth Treatment: The Use of Platelet-Released Growth Factors for Treating Androgenetic Alopecia by Activating Hair Follicle Stem Cells
Platelet-released growth factors can treat hair loss by activating hair follicle stem cells, blocking certain pathways, and controlling inflammation and fibrosis.
research An Uncontrolled Case Series Testing Cryo-Chilled Carbon Dioxide as a Novel Amplification of a Nano-Botanical Multi-Acting Therapy in Advanced Stage Androgenetic Alopecia
The treatment showed promising results in improving advanced-stage hair loss.
research 52243 AH-001: An Emerging Androgen Receptor Degrader Showing Therapeutic Potential in Addressing Androgenetic Alopecia
AH-001 could be a safer and more effective treatment for hair loss.
research Novel Androgen Receptor Degrader for Androgenetic Alopecia Application
research Safety and Efficacy of a Topical Treatment (SM04554) for Androgenetic Alopecia: Results from a Phase 1 Trial
Dutasteride more effective than finasteride for hair growth; SM04554 safe and potentially effective for hair loss.
research Application of Autologous Concentrated Growth Factor in Treating Androgenetic Alopecia: 20 Cases
research Is Minoxidil Efficacious and Safe for the Treatment of Androgenetic Alopecia in Men, and If So, What Is the Optimal Strength and Means of Delivery?
5% minoxidil is safe and effective for treating male hair loss.
research Intensive Dutasteride Mesotherapy Protocol With Oral Minoxidil as an Alternative to Antiandrogens in AGA: A Retrospective Analysis of a Hair Restoration Center
Combining dutasteride mesotherapy with oral minoxidil is more effective for hair loss than using oral minoxidil alone.
research Correction to: The Effects of Lower vs Higher Cell Number of Platelet-Rich Plasma on Hair Density and Diameter in Androgenetic Alopecia: A Randomized, Double-Blinded, Placebo, Parallel-Group Half-Scalp IRB-Approved Study
research Finasteride (Propecia) Post-Marketing Treatment of Androgenetic Alopecia (AGA) Patients in Internal Medicine
research Six-Month Prospective Study on the Effects of a Topical Product in Lotion and Shampoo Form Based on Low Molecular Weight Synthetic Thymus Peptides in Chronic Telogen Effluvium and Early Female Androgenetic Alopecia
research Molecular Mechanisms of Androgenetic Alopecia
AGA causes hair loss by shrinking hair follicles due to DHT binding, and can be treated with finasteride and minoxidil.
research Androgenetic Alopecia in Children: Report of 20 Cases
AGA can occur in children with family history; early diagnosis and treatment important.
research Prevalence and Types of Androgenetic Alopecia in Shanghai, China: A Community-Based Study
Chinese men have lower AGA rates than Caucasians, with type III vertex most common; family history is important.
research Distinguishing Androgenetic Alopecia From Chronic Telogen Effluvium When Associated in the Same Patient
Shorter, thinner hairs indicate AGA, while longer, thicker hairs suggest CTE; counting and measuring shed hairs helps diagnose hair loss type.
research Psychological Characteristics of Women with Androgenetic Alopecia: A Controlled Study
Women with AGA often face anxiety, depression, and low self-esteem; psychological support is important.
research The Presence of Trichodynia in Patients With Telogen Effluvium and Androgenetic Alopecia
Trichodynia found in 29% of TE or AGA patients, linked to psychological conditions.
research Finasteride, 1 Mg Daily Administration on Male Androgenetic Alopecia in Different Age Groups: 10-Year Follow-Up
Finasteride effectively increases hair growth in men with AGA, works better for those over 30, and may cause some side effects.
research Hair Counts in Scalp Biopsy of Males and Females with Androgenetic Alopecia Compared with Normal Subjects
AGA patients have fewer hairs and smaller follicles; T:V ratio above 4:1 may indicate AGA.
research Stem Cell Factor/c-Kit Signaling in Normal and Androgenetic Alopecia Hair Follicles
SCF and c-Kit decrease in AGA hair follicles, possibly affecting hair pigmentation and growth.
research Animal Models of Androgen-Dependent Disorders of the Pilosebaceous Apparatus
Testosterone causes hair loss in AGA mice, which are good for testing baldness treatments, and both minoxidil and cyproterone acetate can prevent this hair loss.
research Frequency, Severity, and Related Factors of Androgenetic Alopecia in Dermatology Outpatient Clinic: Hospital-Based Cross-Sectional Study in Turkey
AGA more common in men, increases with age, linked to family history, hypertension, dyslipidemia, and smoking.
research Androgenetic Alopecia and Coronary Artery Disease in Women
Women under 55 with hair loss (AGA) may have a higher risk of heart disease (CAD).
research Androgenetic Alopecia and Insulin Resistance: Are They Truly Associated?
No true link between AGA and insulin resistance, but coexistence may worsen AGA.
research Androgenetic Alopecia in COVID-19: Comparison to Age-Matched Epidemiologic Studies and Hospital Outcomes With or Without the Gabrin Sign
AGA linked to worse COVID-19 outcomes in men.
research Platelet-Rich Plasma for the Treatment of Androgenic Alopecia: A Systematic Review
Platelet-Rich Plasma (PRP) is a low-risk treatment for Androgenic Alopecia (AGA) that generally improves hair count or density, but more research is needed for optimization.
research Phototrichogram Findings in Women with Androgenetic Alopecia
Women with AGA have less hair on midscalp, more thin and non-growing hair.
research Platelet-Rich Plasma for Hair Restoration
Platelet-Rich Plasma (PRP), a substance from a patient's own blood, can stimulate hair regrowth in people with Androgenetic Alopecia (AGA) who haven't had success with other treatments, but more research is needed to optimize its use.